Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator
Kathy Giusti, a multiple myeloma patient, is the Founder of the Multiple Myeloma Research Foundation (MMRF) and currently serves on its Board of Directors. Giusti is also the Faculty Co-Chair of the Kraft Precision Medicine Accelerator at Harvard Business School. She is recognized as a pioneer of precision medicine, a champion of open-access data sharing, and a strong advocate for patient engagement in their treatment and care and as part of the research process.
Since founding the MMRF in 1998, Giusti has led the Foundation in establishing collaborative research models in the areas of tissue banking, genomics, and clinical trials that are dramatically accelerating the pace at which lifesaving treatments are brought to patients.
Giusti also currently serves as Co-Chair of the HBS Kraft Precision Medicine Accelerator, a $20M endowed program provided by Robert Kraft and the Kraft Family Foundation. Convening best-in-class leaders from across science, business and technology, the mission of the HBS Kraft Accelerator is to speed breakthroughs in precision medicine for all cancers.
Giusti was named #19 on Fortune's "World's 50 Greatest Leaders" list and listed as one of TIME magazine's "100 Most Influential People in the World". She has been recognized by Fortune Magazine as one of "34 Leaders Who Are Changing Healthcare" and "Top 3 Business Leaders Disrupting Healthcare". She recently received the 2017 Precision Medicine World Conference Pioneer Award. Giusti served on President Obama's Precision Medicine Initiative Working Group and has served as an advisor to Vice President Biden's Cancer Moonshot program.
Giusti has more than two decades of experience in the pharmaceutical industry. She received her MBA from Harvard Business School and holds an honorary Doctorate from the University of Vermont.